Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Needle-free nasal tetracosactide test versus intravenous Synacthen in healthy volunteers
ISRCTN62724177Phase 2Completed
- Sponsor
- Sheffield Children's Hospital
- Start
- Dec 2023
- Modality
- Small Molecules, Peptides
01
Overview
Phase 2, randomised, double-blind trial of Nasacthin and tetracosactide hexaacetate in hypoadrenocorticism, sponsored by Sheffield Children's Hospital. Primary endpoints: Mean serum cortisol concentration after Nasacthin versus Synacthen at 30 minutes, Threshold response concordance between Nasacthin and Synacthen and 2 more. Started Dec 2023; status: completed.
02
Drugs
Nasacthintetracosactide hexaacetate
03
Conditions
hypoadrenocorticism
Beyond the preview
Go deeper on ISRCTN62724177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN62724177.